The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
about
Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer modelThe adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives.Minimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.
P2860
The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The combined use of Camellia s ...... nduced osteolysis mouse model.
@en
type
label
The combined use of Camellia s ...... nduced osteolysis mouse model.
@en
prefLabel
The combined use of Camellia s ...... nduced osteolysis mouse model.
@en
P2093
P2860
P50
P1476
The combined use of Camellia s ...... induced osteolysis mouse model
@en
P2093
Andreas Evdokiou
Grace Gar-Lee Yue
Julia Kin-Ming Lee
Ke-Wang Luo
Ping-Chung Leung
P2860
P2888
P304
P356
10.1007/S00432-014-1882-1
P577
2014-11-28T00:00:00Z